A prophylactic a-Gal-based glycovaccine effectively protects against murine acute Chagas disease.

Portillo S, Zepeda BG, Iniguez E, Olivas JJ, Karimi NH, Moreira OC, Marques AF, Michael K, Maldonado RA, Almeida IC. A prophylactic a-Gal-based glycovaccine effectively protects against murine acute Chagas disease. NPJ Vaccines. 2019; 4:13.

View in: PubMed

authors with profiles

Rosa A. Maldonado
Igor C. Almeida
Katja Michael

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support